Science News

NEW YORK--(BUSINESS WIRE)--The Food Allergy Fund (FAF) today convened scientists, investors, policymakers, and advocates at its annual Summit in New York City, unveiling advances that mark a pivotal shift in food allergy care: from delayed detection and limited treatment options toward earlier intervention and emerging therapies. Highlights included first-of-their-kind findings on AI-powered anaphylaxis detection, progress in repurposing FDA-approved drugs as allergy treatments, and the debut o...

IDAHO FALLS, Idaho--(BUSINESS WIRE)--NuCube Energy and Idaho State University selected for DOE's Nuclear Energy Launch Pad USA to deploy the ART microreactor at ISU's Pocatello campus....

RICHMOND, Va.--(BUSINESS WIRE)--CareScout today announced an initiative with Dr. Art Ulene, the nationally recognized physician and former TODAY Show medical correspondent, tied to his planned July ascent of Mount Kilimanjaro at age 89 – a climb that will culminate as he turns 90. The partnership centers on a simple but expansive idea: showing what’s possible at any age. The engagement will use Ulene’s Kilimanjaro climb as a national storytelling moment aimed at reframing how Americans think ab...

SEATTLE--(BUSINESS WIRE)--EverythingALS, the patient-focused nonprofit leveraging technology and data science to accelerate care and research for ALS, today announced the launch of SAVA, an AI-powered clinical trial matching tool that connects ALS patients with clinical trials they may qualify for. Historically, many patients are unaware of ongoing clinical trials, or their physicians may not know about every available opportunity. SAVA AI changes that by using citizen-driven research and data-...

TALLAHASSEE, Fla. & TAMPA, Fla.--(BUSINESS WIRE)--ReliaQuest and Florida State University (FSU) today announced a new partnership designed to advance research and real-world application of artificial intelligence in cybersecurity. Made possible by a $1.5 million philanthropic investment from ReliaQuest, the collaboration will establish the annual ReliaQuest Innovation Challenge at FSU to incentivize faculty research into some of the most complex use-cases for this dynamic field. The partnership...

BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the AI lab informatics company, today announced that Claude Cowork, Anthropic's agentic AI assistant, is now integrated with the Sapio Platform via Sapio Elain, the AI co-scientist. This integration gives scientists and project leaders a single conversational interface to search, retrieve and analyze data held across their R&D organization and to take actions directly within the Sapio ELN and LIMS. Working autonomously on behalf of the user, Claud...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Axoft, a neurotechnology company, today announced it has raised an oversubscribed $55 million Series A led by C.P. Group Innovation. Alumni Ventures, the Stanford President’s Venture Fund, Hillhouse Investment and Gaorong Ventures also participated in the round. With more than $60 million in total funding raised, Axoft will use the capital to expand its current clinical trials globally and progress U.S. regulatory approval of its implantable Brain-Computer Int...

NORTHBROOK, Ill.--(BUSINESS WIRE)--UL Solutions Inc. (NYSE: ULS), a global leader in applied safety science, today announced the groundbreaking for a new electromagnetic compatibility (EMC) and wireless testing laboratory in Neu-Isenburg, Germany, expanding the company’s testing capacity for large, high-power industrial equipment and appliances, and medical, consumer and automotive products. “Our investment in this exciting new state-of-the-art facility reflects our commitment to meeting custom...

VANCOUVER, British Columbia--(BUSINESS WIRE)--ME Therapeutics Holdings Inc. (“ME Therapeutics” or the “Company”) (CSE: METX) (FSE: Q9T), a publicly listed biotechnology company developing novel cancer fighting drugs that reprogram and redirect immune cells to fight cancer, is pleased to provide an update on recent advances within its in vivo CAR and therapeutic mRNA research and development programs. ME Therapeutics continues to advance its in vivo chimeric antigen receptor (CAR) pipeline. The...

NEW YORK--(BUSINESS WIRE)--Artist and the Machine's AI & Creativity Summit returns to New York featuring leading voices and brands across sectors....